Entera Bio Balance Sheet Health
Financial Health criteria checks 4/6
Entera Bio has a total shareholder equity of $6.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $7.7M and $1.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$6.92m |
| Equity | US$6.45m |
| Total liabilities | US$1.29m |
| Total assets | US$7.74m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5DT's short term assets ($7.3M) exceed its short term liabilities ($1.1M).
Long Term Liabilities: 5DT's short term assets ($7.3M) exceed its long term liabilities ($178.0K).
Debt to Equity History and Analysis
Debt Level: 5DT is debt free.
Reducing Debt: 5DT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5DT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 5DT has less than a year of cash runway if free cash flow continues to grow at historical rates of 2.4% each year.